Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Robb

Showing results (151-160 of 168) with videos related to

Pageof 17
Sort By:
Military Medicine|July 27, 2001
Clinical prognosis of patients with early-stage human immunodeficiency virus (HIV) disease: contribution of HIV-1 RNA and T lymphocyte subset quantitationA E Brown, M J Dolan, N L Michael, et al.
Journal of Medicinal Chemistry|March 1, 1983
Prostaglandin isosteres. 2. Chain-modified thiazolidinone prostaglandin analogues as renal vasodilatorsJ B Bicking, M G Bock, E J Cragoe, et al.
Investigative Ophthalmology & Visual Science|March 30, 2019
Monomethyl Fumarate Protects the Retina From Light-Induced RetinopathyDan Jiang, Renee C Ryals, Samuel J Huang, et al.
Journal of Virology|September 6, 2005
In-depth analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfectionF E McCutchan, M Hoelscher, S Tovanabutra, et al.
Heliyon|July 20, 2017
HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIVJ Hinkula, S Petkov, K Ljungberg, et al.
The Journal of Pathology|September 1, 2016
ANGPTL4-αvβ3 interaction counteracts hypoxia-induced vascular permeability by modulating Src signalling downstream of vascular endothelial growth factor receptor 2Elisa Gomez Perdiguero, Athanasia Liabotis-Fontugne, Mélanie Durand, et al.
Oncotarget|February 14, 2018
Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapyCaroline M Robb, Smit Kour, Jacob I Contreras, et al.
JCI Insight|July 17, 2025
Chronic integrated stress response causes dysregulated cholesterol synthesis in white matter diseaseKarin Lin, Nina Ly, Rejani B Kunjamma, et al.
Journal of Medicinal Chemistry|May 8, 2009
Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptorRamin Faghih, Sujatha M Gopalakrishnan, Jens Halvard Gronlien, et al.
Oncotarget|July 9, 2020
Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapyCaroline M Robb, Smit Kour, Jacob I Contreras, et al.
Pageof 17

Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Military Medicine|July 27, 2001
Clinical prognosis of patients with early-stage human immunodeficiency virus (HIV) disease: contribution of HIV-1 RNA and T lymphocyte subset quantitationA E Brown, M J Dolan, N L Michael, et al.
Journal of Medicinal Chemistry|March 1, 1983
Prostaglandin isosteres. 2. Chain-modified thiazolidinone prostaglandin analogues as renal vasodilatorsJ B Bicking, M G Bock, E J Cragoe, et al.
Investigative Ophthalmology & Visual Science|March 30, 2019
Monomethyl Fumarate Protects the Retina From Light-Induced RetinopathyDan Jiang, Renee C Ryals, Samuel J Huang, et al.
Journal of Virology|September 6, 2005
In-depth analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfectionF E McCutchan, M Hoelscher, S Tovanabutra, et al.
Heliyon|July 20, 2017
HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIVJ Hinkula, S Petkov, K Ljungberg, et al.
The Journal of Pathology|September 1, 2016
ANGPTL4-αvβ3 interaction counteracts hypoxia-induced vascular permeability by modulating Src signalling downstream of vascular endothelial growth factor receptor 2Elisa Gomez Perdiguero, Athanasia Liabotis-Fontugne, Mélanie Durand, et al.
Oncotarget|February 14, 2018
Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapyCaroline M Robb, Smit Kour, Jacob I Contreras, et al.
JCI Insight|July 17, 2025
Chronic integrated stress response causes dysregulated cholesterol synthesis in white matter diseaseKarin Lin, Nina Ly, Rejani B Kunjamma, et al.
Journal of Medicinal Chemistry|May 8, 2009
Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptorRamin Faghih, Sujatha M Gopalakrishnan, Jens Halvard Gronlien, et al.
Oncotarget|July 9, 2020
Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapyCaroline M Robb, Smit Kour, Jacob I Contreras, et al.
Pageof 17